SEC fundamentals

PLUS THERAPEUTICS, INC. (CNSY)

as filed in 10-Q FY2026, period ended Sep 30, 2026 · updated Nov 14, 2026
Total Assets
$12.2M
Stockholders' Equity
-$923,000
Cash & Equivalents
$879,000
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Sep 30, 2026 · View filings on EDGAR ↗

Quarter-end price

Derived from SEC filings · not a live quote · USD per share

Dec 31, 2025
$0.5123
From 27 filers
Mar 31, 2026
$0.1626
From 22 filers
Jun 30, 2026
$4.37
From 22 filers
Sep 30, 2026
$1.87
As reported

29 quarter-ends on file; the newest 4 shown. Each price is as of its date, from the filings that reported it, and is never adjusted; the full series with each price's sources is in the docs.

In its 10-Q for the period ended Sep 30, 2026, PLUS THERAPEUTICS, INC. reported revenue of $722,000, net income of -$8.7M, and total assets of $12.2M. Every figure below is taken directly from PLUS THERAPEUTICS, INC.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2016–FY2025 · as reported

$5.8M-$8.4M-$22.7M
FY2016FY2019FY2022FY2025
Revenue$5.2MNet income-$22.4M
FY2016 revenue
$4.7M
FY2025 revenue
$5.2M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$5.2M-$22.4M
FY2024$5.8M-$13.0M
FY2023$4.9M-$13.3M
FY2022—-$20.3M
FY2021—-$13.4M
FY2020—-$8.2M
FY2019—-$10.9M
FY2018$3.7M-$12.6M
FY2017$2.7M-$22.7M
FY2016$4.7M-$22.0M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
10-QNov 13, 2026on EDGAR ↗
8-KNov 13, 2026on EDGAR ↗
8-KNov 12, 2026on EDGAR ↗
8-KOct 2, 2026on EDGAR ↗
8-KSep 10, 2026on EDGAR ↗
8-KAug 14, 2026on EDGAR ↗
10-QAug 14, 2026on EDGAR ↗
8-KAug 4, 2026on EDGAR ↗
8-KJun 5, 2026on EDGAR ↗
8-KMay 15, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Sep 30, 2026 · 10-Q

Total Assets$12.2Msource ↗
Stockholders’ Equity-$923,000source ↗
Cash & Equivalents$879,000source ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Sep 30, 2026

Revenue$722,000source ↗
Net Income-$8.7Msource ↗
Operating Income-$7.5Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$2.1Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Sep 30, 2026

EPS (diluted)$-1.14source ↗
EPS (basic)$-1.14source ↗
Shares Outstanding9.8Msource ↗
Cash from Operations-$7.7Msource ↗
Cash from Financing$4.2Msource ↗
Cash from Investing$2.0Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

No open-market Form 4 transactions filed in the last 180 days.

Restatement history

Point-in-time

9 of 456 annual fact-keys were materially restated between filings: what PLUS THERAPEUTICS, INC. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches CNSY’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Starter extends the ratios to 20 quarters and adds the Piotroski F-score and accruals quality score; Analyst extends the trajectory to up to 20 years. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Starter removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/CNSY

MCP tool: get_sec_fundamentals ticker=CNSY

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/CNSY/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=CNSY as_of=YYYY-MM-DD

Quarter-end prices derived from SEC filings, with their sources and splits
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/prices/CNSY/history?frequency=quarter

MCP tool: get_sec_price_history ticker=CNSY frequency=quarter

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/CNSY/history

MCP tool: get_fundamentals_history ticker=CNSY

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/CNSY

MCP tool: get_financial_health ticker=CNSY

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.